Fellowship · Cincinnati, OH
Sponsored by University of Cincinnati Medical Center Inc. · Director Scott Neltner
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
The New England journal of medicine · 2023 · 156 citations · Alan Fleischer
United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.
Journal of the American Academy of Dermatology · 2021 · 208 citations · Pushkar Aggarwal, Alan Fleischer
Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review.
Dermatology and therapy · 2021 · 44 citations · Alan Fleischer
Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX.
Journal of the American Academy of Dermatology · 2026 · 5 citations · Alan Fleischer
Global Epidemiology of Urticaria: Increasing Burden among Children, Females and Low-income Regions.
Acta dermato-venereologica · 2021 · 35 citations · Cristin Shaughnessy, Alan Fleischer
IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-Analysis.
Journal of clinical medicine · 2024 · 14 citations · Pushkar Aggarwal, Alan Fleischer
The utility of artificial intelligence platforms for patient-generated questions in Mohs micrographic surgery: a multi-national, blinded expert panel evaluation.
International journal of dermatology · 2024 · 8 citations · Matthew DaCunha
The ambulatory care burden of nail conditions in the United States.
The Journal of dermatological treatment · 2021 · 15 citations · Alan Fleischer